🔎 Trials Near Me

Akèy › Kansè pwostat › Illinois › Peoria

Etid klinik pou Kansè pwostat nan Peoria, IL

9 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Peoria (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Ap rekriteFaz 3
  • Illinois CancerCare-Peoria, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi lwen
  • Illinois CancerCare-Canton, Canton · 25 mi lwen
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Illinois CancerCare-Peoria, Peoria
  • Methodist Medical Center of Illinois, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi lwen
  • ak 1 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Ap rekriteFaz 2
  • Illinois CancerCare-Peoria, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi lwen
  • Illinois CancerCare-Canton, Canton · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06632977

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Ap rekriteFaz 3
  • Illinois Cancer Care ( Site 0104), Peoria
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06136650

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Ap rekriteFaz 3
  • OSF Saint Francis Medical Center, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi lwen
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Ap rekriteFaz 3
  • Illinois CancerCare-Peoria, Peoria
  • Methodist Medical Center of Illinois, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi lwen
  • ak 1 plis
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Ap rekriteFaz 3
  • Illinois CancerCare-Peoria, Peoria
  • Methodist Medical Center of Illinois, Peoria
  • Illinois CancerCare-Pekin, Pekin · 9 mi lwen
  • ak 1 plis
Laj 18 ak plis · Gason · Mizajou Jan 22, 2026 · NCT06470243

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Ap rekriteFaz 4
  • Methodist Medical Center of Illinois, Peoria
Laj 18 a 64 · Tout sèks · Mizajou Jan 22, 2026 · NCT04373564

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Ap rekriteFaz 3
  • Illinois CancerCare-Peoria, Peoria
  • Methodist Medical Center of Illinois, Peoria
  • OSF Saint Francis Medical Center, Peoria
  • ak 2 plis
Laj 18 ak plis · Gason · Mizajou Sep 11, 2025 · NCT03678025

Etid Kansè pwostat nan lòt vil

Lòt etid nan Peoria

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.